Arena Pharma Stock On Tear Ahead Of Diet Pill Review
UPDATE: Arena Pharmaceuticals (ARNA) advanced 3.9% in afternoon trading Wednesday, continuing an upward climb in which its stock price has risen every day since June 7, rising 57% in that time. Vivus (VVUS), which like Arena has a new diet drug up for consideration before the Food and Drug Administration, rose 0.3% to about 27 ...
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here